- Cannabis
Strategic Ventures injects capital, expertise and network to expand its
portfolio
- The
company is developing a family of brands with its portfolio approach
- Company
management believes that there is significant opportunity in the industry
to create and control specific industry niches
Cannabis Strategic Ventures, Inc. (OTC: NUGS) acquires and
develops companies within the cannabis and ancillary sectors that are in
startup and growth stages. Cannabis Strategic Ventures, based in Los Angeles,
California, injects capital, expertise and network to hyper-grow its portfolio.
The company concentrates on supporting entrepreneurial growth within the
fast-growing legal cannabis sector and works to provide a public vehicle entity
to investors looking to invest in a vertically integrated company that
approaches the cannabis and cannabidiol industries from a global viewpoint.
The legal cannabis industry is positioned for significant
growth. Forbes notes (http://ibn.fm/4QP6v)
that, “Spending on legal cannabis worldwide is expected to hit $57 billion by
2027. The adult-use (recreational) market will cover 67% of the spending;
medical marijuana will take up the remaining 33%.” The biggest group of
cannabis buyers will be in North America. Spending is forecast to increase from
$9.2 billion in 2017 to $47.3 billion in 2027.
To this end, Cannabis Strategic Ventures’ management
believes that there is a major opportunity in the industry to create and
control specific industry niches by developing cannabis consumer brands to
complement the organization’s hard assets. The company is bringing together
expertise in the cultivation, product sales and personnel services for the
cannabis sector and offers, via a select portfolio of subsidiaries, products,
technologies and services made to match the growth aspects of cannabis cultivators,
manufacturers, dispensaries and other cannabis industry participants.
With its portfolio approach, Cannabis Strategic Ventures is
developing a collection of brands. These brands cover varied areas including
cannabis oil, concentrate extraction services and staffing for the cannabis
sector, as well as cannabis cultivation (http://ibn.fm/lSz9v). The company’s portfolio comprises
Halo Filters, Fitamins, The Asher House Wellness and Pure Applied Sciences.
Halo Filters is a unique filter material for protecting the
lungs from harmful toxins and chemicals. Fitamins is a proprietary joint
formula infused with cannabidiol to enhance health and wellness. The Asher
House offers whole plant-based cannabidiol for pets.
Pure Applied Sciences offers its PureOrganix brand. This is
a line of organic and pure cannabis oils and related accessories. Pure Applied
Sciences has a cannabis concentrate extraction services agreement with CP
Logistics LLC. Through this agreement, CP Logistics will perform white label
services, producing high quality, ultra-purified cannabis extracts for Pure
Applied Sciences out of its Sun-Oil Facility in Cathedral City, California. It
will do so under the PureOrganix brand name (http://ibn.fm/cVwSV).
Cannabis Strategic Ventures continues to center on investing
in and securing market share in the $10 billion cannabis and $900 million hemp
industries. An umbrella company, it is expanding its product lines to include
beauty products while it adds cultivation to its portfolio for better vertical
integration. This strategy offers considerable growth potential for the company
and its stakeholders in diverse verticals.
For more information, visit the company’s website at www.CannabisStrategic.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
